Filter by:

Role All
Research group All
Institute All

Prof. Marte Lie Høivik

Scientific Advisory Board
Marte Lie Høivik, a leading researcher in IBD, is a professor of Gastroenterology at the University of Oslo and Senior Consultant and head of the IBD unit at the Department of Gastroenterology, Oslo University Hospital. Her research focuses on the role of the microbiome in IBD, as well as the relationship between genetic factors and

Prof. Arthur Kaser

Scientific Advisory Board
Arthur Kaser is chief gastroenterologist at Addenbrooke’s (Cambridge, UK), experienced in IBD and clinical studies and has an excellent track-record in mucosal immunology.

Prof. Christine Moissl-Eichinger

Scientific Advisory Board
Christine Moissl-Eichinger, a leading researcher in microbiome science, is a professor at the Medical University of Graz, Austria. She focuses on the human microbiome and its interactions with environmental microbiomes, with a particular interest in archaea.

Prof. Ng Siew Chien

Scientific Advisory Board
Ng Siew Chien is an Associate Dean (Research) and Professor in the Department of Medicine and Therapeutics at the Chinese University of Hong Kong (CUHK). She is also the Director of the Microbiota I-Center (MagIC) and Associate Director of the Centre for Gut Microbiota Research. With expertise in IBD, fecal microbiota transplantation, colorectal cancer, and

Prof. Jeroen Raes

Scientific Advisory Board
Jeroen Raes (VIB/KU Leuven, Belgium) is one of the key microbiome researchers in Europe that has been involved in the EU microbiome initiative MetaHIT and who is currently driving the Flemish Gut Flora Project.

Prof. Melanie Schirmer

Scientific Advisory Board
Melanie Schirmer has worked as a computational scientist at the Broad Institute of MIT and Harvard & Harvard T.H. Chan School of Public Health (USA), studying the human microbiome and identifying microbial factors involved in the pathogenesis of IBD. Afterwards, she established her own independent research group at Technical University of Munich (TUM) with an

Prof. Stefan Schreiber

Scientific Advisory Board
Stefan Schreiber, a renowned expert in IBD, one of three directors of the Institute of Clinical Molecular Biology and director of the Clinic for Internal Medicine I at Kiel Campus of the University Hospital Schleswig-Holstein.

Dr. rer. nat. Marie Vallier

Alumni
Institute for Experimental Medicine (IEM) / Kiel University (CAU), Max Planck Institute for Evolutionary Biology (MPI)

Dr. med. Laura Katharina Sievers

Associated Scientist
Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), I. Medical Department / University Medical Center Schleswig-Holstein (UKSH), Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH)
P3 (Phase 1)

Prof. Dr. med. Jan Rupp

Principle Investigator
Department of Infectious Diseases and Microbiology (KIM) / Lübeck University (UzL), University Medical Center Schleswig-Holstein (UKSH)
P8 (Phase 1)

Malte Rühlemann

Postdoctoral Researcher, Associated Scientist
Kiel University (CAU), Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH)
P2 (Phase 2)

Hina Ayub

Doctoral Researcher, Associated Scientist
Kiel University (CAU), Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH)
P2 (Phase 2)

Andre Geisler

Doctoral Researcher, Associated Scientist
Kiel University (CAU), Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH)
P2 (Phase 2)

Zaira Zafroon

Doctoral Researcher
Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH)
P2 (Phase 2)

Evgeniya Lokes

Doctoral Researcher, Associated Scientist
Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH)
P1 (Phase 2)

Kostas Sivickis

Doctoral Researcher
Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH)
P1 (Phase 2)

Johanna Saalfrank

Doctoral Researcher, Associated Scientist
Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH)
P1 (Phase 1),
P1 (Phase 2)

Prof. Dr. med. Florian Tran

Associated Scientist
Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), I. Medical Department / University Medical Center Schleswig-Holstein (UKSH), Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH)
P3 (Phase 1),
P3 (Phase 2)

Lea Järke

Doctoral Researcher, Associated Scientist
Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH)
P5 (Phase 1),
P4 (Phase 2)

Participating Institutes